CPAP support for acute low-oxygen respiratory failure in Burkina Faso
Official title: Use of (Continous Positive Airway Pressure) CPAP in the Management of Acute Hypoxemic Respiratory Failure
Run by Université NAZI BONI · NCT06912360 · Data updated 2026-11-12
This program will try CPAP (a simple non‑electric breathing support) to see if it reduces the need for intubation in adults with acute low‑oxygen respiratory failure in Burkina Faso.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Université NAZI BONI Academic / other |
| Locations | 4 sites (Bobo-Dioulasso, Houet and 3 other locations) |
| Status | Recruiting |
| Started | July 9, 2025 |
| Main results expected | January 20, 2026 |
| Study ends | February 20, 2026 |
| Registry record updated | July 28, 2025 |
| Trial ID | NCT06912360 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with acute respiratory distress (respiratory rate ≥25) or needing more than 6 L/min of oxygen to maintain SpO2 ≥92% and no contraindications to CPAP are the intended participants.
✕Probably not a fit
Patients with COPD or asthma exacerbations, moderate to large undrained pleural effusion, contraindications to CPAP, pregnant or breastfeeding people, or those deprived of liberty are unlikely to benefit or be eligible for this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults presenting with acute hypoxemic respiratory failure in the emergency departments of four university hospitals in Burkina Faso will receive Boussignac‑type CPAP as a non‑invasive respiratory support. The primary outcome is whether CPAP reduces the occurrence of intubation criteria within seven days. Secondary outcomes include 28‑day mortality, oxygenation measured by SpO2/FiO2, hospital length of stay, and safety events. Ancillary analyses will examine the role of ultrasound, determine etiologies and prognosis of ARF and ARDS, and estimate the cost of care.
Why it matters
Potential benefit: If successful, CPAP could lower the need for invasive ventilation and reduce deaths and ICU admissions where mechanical ventilators are scarce.
How similar studies have gone: Non‑invasive supports such as CPAP and high‑flow oxygen reduced intubation rates during the COVID‑19 pandemic, but evidence specifically for low‑resource Boussignac CPAP deployment is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients aged 18 years and older will be included in the study if they meet at least one of the following criteria : * Acute respiratory distress, defined as dyspnea respiratory rate ≥ 25 cycles/min * Hypoxemia, defined as the need for more 6 liters of oxygen to maintain an oxygen saturation (SpO2) of ≥ 92%. The fraction of inspired oxygen (FiO2) will be estimated using the 3% rule. Exclusion Criteria: Patients with any of the following criteria will not be included in the study: * Pregnant or breastfeeding women * Persons deprived of their liberty * Exacerbation of asthma, chronic obstructive pulmonary disease, or another chronic respiratory disease * Moderate to large amount of unilateral or bilateral undrained pleural effusion * Contraindication to CPAP: patient refusal, undrained pneumothorax, chest injury, repeated or large vomiting, upper gastrointestinal bleeding, craniofacial trauma, severe upper airway obstruction, or tetraplegia in the initial phase * Cardiac arrest, severe arrhythmias, shock requiring the use of vasopressors (norepinephrine, adrenaline, dopamine) * Altered level of consciousness (Glasgow Coma Scale score \< 13), repeated seizures, or status epilepticus * Medical decision to limit treatment: no intubation, no admission to intensive care * Refusal to participate in the study or participation in another interventional study on respiratory distress or acute respiratory failure.
Where it's running
-
Centre Hospitalier Universitaire Souro Sanou
Bobo-Dioulasso, Houet, Burkina Faso Recruiting -
CHU Yalgado Ouedraogo
Ouagadougou, Kadiogo, Burkina Faso Not yet recruiting -
CHU Tengandogo
Ouagadougou, Kadiogo, Burkina Faso Not yet recruiting -
CHU Bogodogo
Ouagadougou, Kadiogo, Burkina Faso Not yet recruiting
Study contacts
- Principal investigator: Ismael Guibla, doctor — University Hospital Souro Sanou, Burkina Faso
- Study coordinator: Ismael Guibla, doctor
- Email: ismaelguibla@gmail.com
- Phone: +22676135113
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sodium bicarbonate with bedside electrical impedance tomography to map lung blood flow in ventilated adults
This project will try whether a small sodium bicarbonate injection combined with bedside electrical impedance tomography can map lung blood flow in adults on mechanical ventilation, compared with hypertonic saline.
-
Feasibility of using a weight-adjusted saline bolus with electrical impedance tomography to map lung perfusion in children
This pediatric pilot tests whether a carefully dosed saline bolus with electrical impedance tomography can map lung perfusion and ventilation distribution in kids with acute respiratory failure.
-
Predicting HFNO failure within 72 hours using a physiology-informed model at 30 minutes
This study tests a model that uses Heart–lung physiology and 30-minute data to see if high-flow nasal oxygen will fail in adults with acute hypoxemic respiratory failure.
-
Bedside ultrasound of the IVC to find pulmonary edema in adults with sudden severe breathlessness
This project will test whether bedside ultrasound measurements of how the inferior vena cava changes with breathing can help identify pulmonary edema in adults who come to the emergency department with sudden breathing failure.
-
Brain–lung interaction during sudden severe low-oxygen respiratory failure
We will try EEG, NIRS, and neck muscle recordings before and one hour after starting high-flow nasal oxygen in adults with sudden low-oxygen respiratory failure to see how the brain and lungs interact.
-
Comparing SpO2 targets and oximeters during high-flow nasal oxygen
This study tests whether two different pulse oximeters (Nonin and Philips) and two SpO2 targets (90% vs 94%) change the amount of oxygen (FiO2) set for adults in the ICU receiving high-flow nasal oxygen.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.